Together, these studies support a broadly consistent role for m6A as a post-transcriptional amplifier of PD-L1, executed by IGF2BP readers and modulated by demethylases in a tumor-type–dependent manner (57, 96). The gene discussed is CD274; the disease is neoplasm.